Inrebic 100 mg – DIN 02502445
Inrebic is Fedratinib Hydrochloride 100 mg (capsule), sold in Canada. It is used for primary myelofibrosis. It is supplied by Bristol-Myers Squibb Canada. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Fedratinib Hydrochloride 100 mg
- Brand
- Inrebic
- Strength
- 100 mg
- Used for
- Primary myelofibrosis
- Form
- Capsule
- Manufacturer
- Bristol-Myers Squibb Canada
- Sold in
- Canada
- DIN
- 02502445
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Fedratinib Hydrochloride used for?
Fedratinib Hydrochloride is used for primary myelofibrosis.
Official uses from the US prescribing label
INREBIC® is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF).
From the FDA-approved label on DailyMed (published Aug 03, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02502445.
- It names Inrebic, Fedratinib Hydrochloride 100 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Inrebic by Bristol-Myers Squibb Canada.
In Canada: prescription only.
Ingredients
Active: Fedratinib (Fedratinib Hydrochloride)